Coral Laboratories Ltd.
| BSE: 524506 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE683E01017 |
| BSE 16:01 | 27 Jun | 236.00 |
-4.15 (-1.73%) |
OPEN
241.55 |
HIGH
252.95 |
LOW
234.95 |
| NSE 05:30 | 01 Jan | Coral Laboratories Ltd |
| OPEN | 241.55 |
| PREVIOUS CLOSE | 240.15 |
| VOLUME | 1653 |
| 52-Week high | 570.00 |
| 52-Week low | 225.05 |
| P/E | 10.13 |
| Mkt Cap.(Rs cr) | 84 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Coral Laboratories Ltd. (CORALLABS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 521.30 | -5.10 | -0.97 | 15823.68 |
| Cipla | 932.25 | -1.15 | -0.12 | 13900.58 |
| Dr Reddy's Labs | 4317.15 | 8.40 | 0.19 | 13349.10 |
| Sun Pharma.Inds. | 835.95 | 11.85 | 1.44 | 12803.21 |
| Lupin | 629.10 | -0.85 | -0.13 | 11055.93 |
| Apollo Hospitals | 3795.45 | -40.15 | -1.05 | 9153.00 |
| Zydus Lifesci. | 353.90 | 0.20 | 0.06 | 7790.40 |
| Glenmark Pharma. | 385.45 | 1.70 | 0.44 | 7567.93 |
| Alkem Lab | 3030.25 | 26.40 | 0.88 | 7219.68 |
| Divi's Lab. | 3679.05 | -1.35 | -0.04 | 6798.61 |
| Torrent Pharma. | 2858.25 | -17.25 | -0.60 | 6450.83 |
| Ipca Labs. | 911.50 | 22.55 | 2.54 | 5114.11 |
| Alembic Pharma | 749.30 | 23.20 | 3.20 | 5051.44 |
| Laurus Labs | 467.05 | 0.45 | 0.10 | 4707.04 |
| Abbott India | 17942.70 | -145.30 | -0.80 | 4310.02 |
| Gland Pharma | 2658.60 | 14.90 | 0.56 | 3462.88 |
| Glaxosmi. Pharma | 1500.85 | 1.10 | 0.07 | 3193.74 |
| Granules India | 267.50 | 10.85 | 4.23 | 3134.98 |
| Sanofi India | 6425.00 | 15.00 | 0.23 | 2956.60 |
| Ajanta Pharma | 1258.00 | 8.15 | 0.65 | 2718.59 |
Quick Links for Coral Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
